CervoMed's three largest insider shareholders as of August 04, 2026 are Sylvie Gregoire (Director, 1.50Mn shares), John J Alam (Ceo President, 1.50Mn shares), Joshua S Boger (Director, 840.45K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| John J Alam | Ceo President | 1,484,078 | 12,500 | 19 Nov, 2025 |
| Joshua S Boger | - | 0 | 840,451 | 28 Feb, 2024 |
| Sylvie Gregoire | - | 1,484,078 | 12,500 | 19 Nov, 2025 |
| Robert Joseph Jr. Cobuzzi | President Ceo | 1,616 | 0 | 03 Feb, 2023 |
| William Robert Elder | Cfo, Gc Secretary | 12,500 | 0 | 19 Nov, 2025 |
| Diana M Lanchoney | - | 294 | 0 | 30 Jun, 2023 |
| Matthew Winton | Chief Commercial And Business | 15,000 | 0 | 19 Nov, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 11 Feb, 2026 | Matthew Winton | Stock Option (Right to Buy) | A | 30,000 | $0.00 | 30,000 | D | A |
| 11 Feb, 2026 | William Robert Elder | Stock Option (Right to Buy) | A | 30,000 | $0.00 | 30,000 | D | A |
| 11 Feb, 2026 | William Robert Elder | Stock Option (Right to Buy) | A | 30,000 | $0.00 | 30,000 | D | A |
| 11 Feb, 2026 | Rosch Mark De | Stock Option (Right to Buy) | A | 30,000 | $0.00 | 30,000 | D | A |
| 11 Feb, 2026 | Rosch Mark De | Stock Option (Right to Buy) | A | 30,000 | $0.00 | 30,000 | D | A |
| 11 Feb, 2026 | Matthew Winton | Stock Option (Right to Buy) | A | 30,000 | $0.00 | 30,000 | D | A |
| 11 Feb, 2026 | William Robert Elder | Stock Option (Right to Buy) | A | 30,000 | $0.00 | 30,000 | D | A |
| 11 Feb, 2026 | John J Alam | Stock Option (Right to Buy) | A | 75,000 | $0.00 | 75,000 | D | A |
| 11 Feb, 2026 | Rosch Mark De | Stock Option (Right to Buy) | A | 30,000 | $0.00 | 30,000 | D | A |
| 11 Feb, 2026 | Sylvie Gregoire | Stock Option (Right to Buy) | A | 75,000 | $0.00 | 75,000 | I | A |
| 11 Feb, 2026 | Matthew Winton | Stock Option (Right to Buy) | A | 30,000 | $0.00 | 30,000 | D | A |
| 11 Feb, 2026 | Kelly Blackburn | Stock Option (Right to Buy) | A | 30,000 | $0.00 | 30,000 | D | A |
| 27 Oct, 2025 | David Quigley | Stock Option (Right to Buy) | A | 16,200 | $0.00 | 16,200 | D | A |
| 27 Oct, 2025 | David Quigley | Stock Option (Right to Buy) | A | 16,200 | $0.00 | 16,200 | D | A |
| 27 Oct, 2025 | David Quigley | Stock Option (Right to Buy) | A | 16,200 | $0.00 | 16,200 | D | A |
| 17 Nov, 2025 | William Robert Elder | Common Stock | A | 1,000 | $8.45 | 10,000 | D | P |
| 17 Nov, 2025 | William Robert Elder | Common Stock | A | 1,000 | $8.45 | 10,000 | D | P |
| 17 Nov, 2025 | Matthew Winton | Common Stock | A | 3,500 | $8.43 | 13,500 | D | P |
| 17 Nov, 2025 | William Robert Elder | Common Stock | A | 1,000 | $8.45 | 10,000 | D | P |
| 17 Nov, 2025 | Matthew Winton | Common Stock | A | 3,500 | $8.43 | 13,500 | D | P |